Author Correction: The randomized ZIPANGU trial of ranibizumab and adjunct laser for macular edema following branch retinal vein occlusion in treatment‑naïve patients

• Toshinori Murata,
• Mineo Kondo,
• Makoto Inoue,
• Shintaro Nakao,
• Rie Osaka,
• Chieko Shiragami,
• Kenji Sogawa,
• Akikazu Mochizuki,
• Rumiko Shiraga,
• Yohei Ohashi,
• Takeumi Kaneko,
• Chikatapu Chandrasekhar,
• Akitaka Tsujikawa,
• Motohiro Kamei

Affiliations

Toshinori Murata

Department of Ophthalmology, Shinshu University School of Medicine

Mineo Kondo

Department of Ophthalmology, Mie University Graduate School of Medicine

Makoto Inoue

Department of Ophthalmology, Kyorin Eye Center, Kyorin University School of Medicine

Shintaro Nakao

Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University

Rie Osaka

Department of Ophthalmology, Faculty of Medicine, Kagawa University

Chieko Shiragami

Department of Ophthalmology, Faculty of Medicine, Kagawa University

Kenji Sogawa

Department of Ophthalmology, Asahikawa Medical University

Akikazu Mochizuki

Novartis Pharma K.K.

Rumiko Shiraga

Novartis Pharma K.K.

Yohei Ohashi

Novartis Pharma K.K.

Takeumi Kaneko

Novartis Pharma K.K.

Chikatapu Chandrasekhar

Novartis Healthcare Pvt. Ltd.

Akitaka Tsujikawa

Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine

Motohiro Kamei

Department of Ophthalmology, Aichi Medical University